novavax inc (NVAX:NASDAQ GS)

Executive Profile*

Background*

Mr. Russell P. Wilson, Rip, has been a Senior Vice President of Business Development at Novavax, Inc. since November 7, 2011. Mr. Wilson is responsible for developing business alliances, license arrangements, and partnering opportunities with pharmaceutical companies and government agencies. He served as the Chief Financial Officer, Principal Accounting Officer and Vice President at Supernus Pharmaceuticals, Inc. since 2009 until October 2011. Mr. Wilson served as a ... Senior Vice President of Intercell USA, Inc. (formerly, Iomai Corp.) from May 2005 to 2008 and also served as its Chief Financial Officer from June 2002 to 2008, General Counsel from March 2000 to 2008 and Secretary since May 2000. Mr. Wilson served as the Principal Accounting Officer of Intercell and was responsible for overseeing Intercell's financial strategy, including external relations with both investment banks and with tax and securities regulators to structure and negotiate business deals. He joined Intercell in 2000 as Vice President of Business Development and was responsible for overseeing the development of Intercell's business relationships and commercialization of products and technologies. Mr. Wilson served as Acting General Counsel at North American Vaccine, Inc. (NAVA), which was sold to Baxter Healthcare in 2000. He served as an Acting General Counsel of NAVA. He holds a B.A. from Princeton University and an M.B.A. and J.D. degree from the University of Virginia.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NVAX:US	$2.02 USD	+0.06

COMPETITOR COMPENSATION